NFKB2 and gastric cancer: NFKB2 has been observed to be upregulated in gastric cancer tissues (Rossi et al., 2019), and its altered expression can collaborate with heterozygous KrasMUT to drive tumorigenesis but decreases the metastatic potential of pancreatic ductal adenocarcinoma (Mueller et al., 2018).